Pharyngitis Therapeutics Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

The pharynx, which is behind the throat and is the site of pharyngitis, or sore throat, is inflamed. The bacterial or viral infections that cause pharyngitis are mostly seen during the colder months of the year. The main causes of pharyngitis are group A streptococcus, chickenpox, croup, whooping cough, measles, adenovirus, and chickenpox. Viral illnesses like the flu, the common cold, and mononucleosis are also frequently to blame for pharyngitis. Amoxicillin and penicillin are the most frequently recommended remedies for sore throats, according to the Centers for Disease Control and Prevention (CDC).

The Pharyngitis Therapeutics Market  expansion can be attributed to the rise in pharyngitis-causing illnesses, including measles, whooping cough, chickenpox, and others. More than 140 000 deaths worldwide were attributed to measles in 2018, according to data from the World Health Organization (WHO).The pharyngitis Therapeutics Market  is primarily brought on by a bacterial infection of the pharynx. According to estimates, the market will grow due to the rising demand for pain and sore throat treatment. Additionally, increasing investment in the creation of measles vaccines is anticipated to spur market expansion.

The global market for treating pharyngitis is divided into three categories based on the route of administration: oral, intravenous, and others. Of these, the oral segment is expected to account for the largest market share during the forecast period due to the accessibility of oral medications and the simplicity of the drug's administration. Because over-the-counter medications are effective and are readily available in pharmacies, the Pharyngitis Therapeutics Market is anticipated to grow significantly in share over the forecast period.

Our market experts' research on the market, both quantitatively and qualitatively, is included in the report. The Pharyngitis Therapeutics Market revenue growth opportunities and trends for the Pharyngitis Treatment industry are highlighted in this report. Additionally, the report provides important data on industry statistics as well as a wide range of dynamic factors, such as supply and demand ratios, production and manufacturing capacities, sales and distribution networks, cost and demand volatility, import/export ratios, profit margins, macro-economic and micro-economic factors, drivers, restraints, risks, challenges, and threats. The report includes a competitive landscape overview, analysis of regional markets, product type outlook, application spectrum, end-use outlook, and technology landscape.

Key Players

The GSK group of companies, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Pfizer Inc., Adamas Pharmaceutical Inc., PLIVA HRVATSKA d.o.o., Mylan N.V., and Genentech Inc. are significant market participants.